https://acuity.news/regulation/ketamine-industry-regulatory-reckoning-spravato-telehealth-2026/Acuity Newsen2026-08-26T11:49:00-06:00Ketamine Went From Psychiatry’s Great Hope to a Regulatory Reckoning, and 2026 Is the Shakeout. The Only FDA-Approved Version Sits Behind a Locked Door; Everything Else Is Off-Label. https://acuity.news/regulation/nebraska-medicaid-aba-rates-sfy27-fee-schedule-policy-caps/Acuity Newsen2026-08-26T07:19:00-06:00Nebraska Medicaid ABA Rates Hold Flat in SFY27 Because No Appropriation Was Made https://acuity.news/regulation/florida-medicaid-aba-task-force-6-57b-spending-month-caps-2026/Acuity Newsen2026-08-25T11:08:00-06:00Florida ABA Task Force Opens Its Medicaid Review With a $6.57 Billion Spending Figure https://acuity.news/regulation/benzodiazepine-overdose-crisis-illicit-supply-prescribed-dependence-2026/Acuity Newsen2026-08-25T06:54:00-06:00Benzodiazepines Are the Overdose Crisis No One Is Watching, and the Treatment System Was Never Built for Them. Street Benzos Meet Prescribed Users. https://acuity.news/regulation/colorado-medicaid-aba-rates-2026-benchmark-federal-audit/Acuity Newsen2026-08-24T15:06:45-06:00Colorado Medicaid ABA Rates Are Pegged to 95 Percent of a Multi-State Benchmark That Includes Nebraska